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Abstract
Endemic and seasonally recurring respiratory viruses are aBackground: 
major cause of disease and death globally. The burden is particularly severe in
developing countries. Improved understanding of the source of infection,
pathways of spread and persistence in communities would be of benefit in
devising intervention strategies.
We report epidemiological data obtained through surveillance ofMethods: 
respiratory viruses at nine outpatient health facilities within the Kilifi Health and
Demographic Surveillance System, Kilifi County, coastal Kenya, between
January and December 2016. Nasopharyngeal swabs were collected from
individuals of all ages presenting with acute respiratory infection (ARI)
symptoms (up to 15 swabs per week per facility) and screened for 15
respiratory viruses using real-time PCR. Paediatric inpatient surveillance at Kilifi
County Hospital for respiratory viruses provided comparative data.
 Over the year, 5,647 participants were sampled, of which 3,029Results:
(53.7%) were aged <5 years. At least one target respiratory virus was detected
in 2,380 (42.2%) of the samples; the most common being rhinovirus 18.6%
(1,050), influenza virus 6.9% (390), coronavirus 6.8% (387), parainfluenza virus
6.6% (371), respiratory syncytial virus (RSV) 3.9% (219) and adenovirus 2.7%
(155). Virus detections were higher among <5-year-olds compared to older
children and adults (50.3% vs 32.7%, respectively; χ (1) =177.3, P=0.0001).
Frequency of viruses did not differ significantly by facility (χ (8) =13.38,
P=0.072). However, prevalence was significantly higher among inpatients than
outpatients in <5-year-olds for RSV (22.1% vs 6.0%; χ (1) = 159.4, P=0.0001),
and adenovirus (12.4% vs 4.4%, χ (1) =56.6, P=0.0001).
 Respiratory virus infections are common amongst ARIConclusions:
outpatients in this coastal Kenya setting, particularly in young children.
Rhinovirus predominance warrants further studies on the health and
socio-economic implications. RSV and adenovirus were more commonly
associated with severe disease. Further analysis will explore epidemiological
transmission patterns with the addition of virus sequence data.
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Introduction
Acute respiratory infection (ARI) is a major cause of morbidity 
and mortality globally, principally affecting young children and 
the elderly, and with majority of the burden occurring in low-
resource settings1,2. Viruses are recognized as major cause of both 
mild ARI and of severe acute lower respiratory tract infection 
(LRTI)3. Respiratory syncytial virus (RSV), rhinovirus and 
influenza A are often identified as the most common viruses 
associated with ARI4,5, but a wide range of viruses are to be found 
in ARI presentations to the hospital and outpatient settings5. The 
changing landscape of ARI due to the widespread use of conju-
gated bacterial vaccines could lead to an increased prominence 
of viral causes of these illnesses6,7.
Given this context, greater emphasis on the control of virus-
associated ARI is likely. Vaccination as an intervention for the 
control of viral respiratory infections faces considerable hurdles. 
These include continuous or rapid pathogen evolution (e.g. 
influenza)8,9, high serotype diversity (e.g. rhinovirus)10 or target 
populations not appropriate for current vaccines (e.g. RSV)11. 
Consequently, innovation in vaccination strategies for these 
pathogens (e.g. targeting of schools and households), mass use 
of antivirals or non-pharmacological methods such as social 
distancing (e.g. school closures), are options to consider. Design-
ing strategies to control respiratory viruses would be assisted 
by detailed knowledge of the patterns of spread, i.e. of distinct 
pathways of transmission in communities, at various social organi-
zational levels from the household, school, local community, 
nationally and beyond country boundaries.
The present work forms part of a larger project under the title 
SPReD (Studies of the Pathways of transmission of Respiratory 
virus Disease), which aims to map patterns of spread of a 
range of respiratory viruses using epidemiological and nucle-
otide sequence data across different settings in Kenya. Here 
we present the baseline results of 1 year of respiratory virus 
epidemiological surveillance at health facilities within a well-
defined coastal Kenyan population and a comparison with 
contemporaneous data on inpatient admissions to Kilifi County 
Hospital (KCH).
Methods
Study site
This study was conducted on the coast of Kenya, within the Kilifi 
Health and Demographic Surveillance System (KHDSS)12–14. The 
KHDSS area was defined and mapped for demographic sur-
veillance, clinical and epidemiological research by the KEMRI 
Wellcome Trust Research Programme (KWTRP) in the year 
2000. It is located in Kilifi County along the coastal fringe and 
covers an area of 891 km2, 50 km north and south, and 30 km 
west, of the KCH. The KHDSS monitors a population of around 
296,000 residents (2016 census) through household enumeration 
visits conducted every 4 months. The major economic activity 
of most residents is subsistence farming of maize, cassava, cashew 
nuts and coconuts, as well as goats and dairy cattle14.
The KHDSS area has 21 public health facilities (including the 
KCH) receiving out-patients, which operate under the Kenya 
Ministry of Health (MoH). In total, nine of these facilities 
were selected for this study: Matsangoni, Ngerenya, Mtondia, 
Sokoke, Mavueni, Jaribuni, Chasimba, Pingilikani and Junju 
(Figure 1). The facilities were purposively selected to provide 
a broad representation across the geographical region, covering 
major road networks into the location and variation in popula-
tion density. All specimen processing and testing was carried 
out at KEMRI-Wellcome Trust Research Programme laboratories 
in Kilifi.
Patient recruitment and specimen collection
Participant recruitment and specimen collection was integrated 
within the routine patient care at the nine selected outpatient 
facilities led by a resident clinician or nurse. Each facility had 
one or two sampling days per week, usually scheduled from 
Monday to Friday, between 9.00 am and 1.00 pm. On each 
sampling day, a study fieldworker stationed at the health facility, 
assisted by the resident clinician or nurse, would describe the study 
to the attending patients. Any person present with listed signs and 
symptoms of ARI would be asked to see the fieldworker for 
further screening and obtainment of consent as they await review 
by the nurse or clinician. Patients of any age presenting with 
one or more ARI symptoms of cough, sneezing, nasal conges-
tion, difficulty breathing, or increased respiratory rate for age 
(as defined by the World Health Organisation15) were eligible. 
New-borns aged less than 7 days and patients with ARI for 
more than 30 days were excluded. Written individual informed 
consent was sought from adult patients and parents/guardians of 
patients below 18 years. The study commenced in December 
2015 with piloting before enhanced surveillance of 15 samples 
per site per week from January to December 2016.
The sample size of 15 samples per site per week was determined 
based on outpatient data on the number of respiratory infection 
cases seen per month per selected health facility and our 
previous experience with inpatient surveillance for respira-
tory viruses at KCH. To optimize the study power to detect a 
diversity of the respiratory viruses, we estimated to collect 
approximately 7000 NPS specimen within a 1-year study period. 
Out of the 7000 NPS, we expected 1050 (15%), 700 (10%), 490 
(7%) and 490 (7%) specimens to be positive for rhinoviruses, 
RSV, coronaviruses, and influenza viruses, respectively.
The selection of participants each week was on a ‘first-come 
first-served’ basis as they presented to the health facility on the 
set sampling days. A standardised questionnaire (Supplementary 
File 1) was used to collect biodata, presenting symptoms as 
well as the treatment provided which was entered directly into 
a study database using a computer tablet. A nasopharyngeal 
swab (NPS) was collected from each participant by inserting 
a sterile nylon-flocked plastic-shafted swab (503CS01, Copan 
Diagnostics, Flocked Swab Technologies, Italy) into one nostril 
to a distance where the tip located in the deep nasopharynx 
and was twisted 3 times before it was gently removed (in total 
taking about 10 seconds)16. The NPS sample was stored in 
universal virus transport media (Copan Diagnostics, USA) and 
kept at approximately 8°C in an ice-packed cool box for return to 
KWTRP within 4 h of collection.
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Ethical considerations
All individuals, parents and guardians gave written informed 
consent for themselves or their children to participate in this 
study. The study was approved by the KEMRI-Scientific and 
Ethical Review Unit (SERU# 3103) and the University of 
Warwick Biomedical and Scientific Research Ethics Committee 
(BSREC# REGO-2015-6102).
Laboratory procedures
NPS collections received at KWTRP virology laboratory were 
stored in 2-ml vials at −80°C until use. Using previously described 
methods17–19, RNA was extracted from the respiratory specimens 
by Qiacube HT using an RNeasy extraction kit (Qiagen, 
Germany) and screened for RSV (A and B), rhinovirus (HRV), 
human coronaviruses (OC43, NL63, E229), influenza viruses 
(FLU-A, B, and C), parainfluenza viruses (PIV 1-4), adenovirus 
(ADV) and human metapneumovirus (HMPV), using a multiplex 
real-time PCR assay system. Samples with cycle threshold 
(Ct) of <35.0 were defined as positive for the target virus. Residual 
NPS samples were stored at −80°C.
Statistical analysis
Statistical analysis was conducted using STATA version 13.1 
(College Station, Texas). Summary statistics were produced 
for the data to give the proportions of virus positives by age 
and by location. Comparative data was obtained from the 
paediatric ward of KCH for patients aged <5 years admitted 
with acute LRTI from a contemporaneous respiratory virus 
surveillance20–23. Chi-squared and Fisher’s exact tests were used to test 
associations of virus occurrence with age, calendar month, 
facility, setting (outpatient or inpatient) and other demographic 
characteristics. Frequency distribution graphs were generated 
for all virus targets. Graphs for temporal patterns for each virus 
were generated.
Figure 1. A map of the Kilifi Health and Demographic Surveillance System (HDSS) area, coastal Kenya, expanded from a map of 
Kenya, showing population density (person per Km2) and the health facilities where the study was conducted in 2016. The red circles 
show the nine participating health facilities while the green markers show the other public health facilities within the KHDSS area.
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Results
Baseline characteristics of participants and sites
A total of 5647 participants were recruited from January to 
December 2016. The median age was 4 years (interquartile 
range (IQR): 1–15 years), 53.6% (n=3029) were children under 
5 years of age, and 42.3% (2389) were male. The frequency of 
distribution of symptoms among participants by site, age and 
virus target are shown in Table 1. Although the proportions of 
each symptom by health facility, age category and virus target, 
were often statistically significantly different (Table 1), the rank 
Table 1. Distribution of respiratory symptoms among study participants from a study of 9 outpatient health facilities in 
Kilifi County coastal Kenya over the year 2016.
Characteristic Fever, % Chest indrawing, %
Crackles, 
%
Wheeze, 
%
Cough, 
%
Nasal 
discharge, 
%
Nasal 
flare, %
Difficulty 
breathing, 
%
Total 
participants, n
Health Facility
Matsangoni 58.4 0.91 0.45 1.82 93.8 68.68 3.48 7.87 661
Ngerenya 58.1 0.48 0.8 1.6 96.3 81.28 0.8 11.36 625
Sokoke 51.5 0.81 1.3 1.63 97.1 80.33 1.46 8.62 616
Mtondia 68.8 1.17 0.58 0.73 96.1 63.41 0.87 5.1 686
Mavueni 68.5 0.78 0.78 1.1 94.2 81.38 5.16 7.82 639
Jaribuni 57.8 0.67 0.5 2.68 97.3 82.58 0.67 6.03 597
Chasimba 53.7 0.97 0.97 1.46 97.1 72.65 0.16 6.8 618
Junju 64.7 0.33 2.12 3.59 90.2 78.92 0.82 11.27 612
Pingilikani 83 0.84 3.04 3.37 92.6 72.18 1.35 21.25 593
χ2 P value 0.0001 0.835 0.0001 0.001 0.0001 0.0001 0.0001 0.0001
Age Category
0–5 mths 63.48 1.91 1.72 2.29 91.97 78.78 4.21 12.62 523
6–11 mths 69.69 0.58 1.16 0.97 95.16 80.66 3.09 10.64 517
12–23 mths 74.64 1.43 2.21 3.64 96.1 82.31 2.6 12.35 769
24–35 mths 73.91 1.27 0.91 3.99 95.47 80.98 2.36 7.79 552
3–4 yrs 75.52 0.6 0.9 1.95 96.26 77.54 1.35 9.13 668
5–9 yrs 71.63 0.26 1.04 0.78 95.21 72.15 0.39 6.61 772
10–19 yrs 55.22 0.43 0.71 1.28 93.87 71.75 1 6.99 701
20–49 yrs 39.87 0.38 0.89 1.77 94.43 68.35 0.38 9.87 791
50–100 yrs 30.51 0.28 0.56 0.56 96.33 66.95 0.28 10.17 354
χ2 P value 0.0001 0.005 0.127 0.0001 0.019 0.0001 0.0001 0.0001
Virus Target
RSV 85.39 2.74 1.37 3.65 95.89 72.6 3.2 13.7 219
Rhino 60.35 1.16 1.26 2.61 94.97 79.79 2.03 10.54 1034
Adeno 82 1 1 0 93 68 1 8 100
Flu 77.9 0 0.85 2.55 97.17 78.47 0.28 7.37 353
Corona 64.62 0 0.36 0.72 96.39 80.14 0.36 5.42 277
PIV 71.74 3 2.48 3.11 98.45 81.68 3.11 13.04 322
HMPV 70.67 0 1.33 0 100 77.33 1.33 6.67 75
χ2 P value 0.0001 0.02 0.398 0.117 0.02 0.024 0.026 0.007
Sex
Male 68.63 1.05 1.67 2.01 95.53 77.98 1.92 10.12 2389
Female 58.36 0.58 0.77 1.93 95.56 73.72 1.44 8.94 3258
χ2 P value 0.0001 0.051 0.002 0.841 0.105 0.0001 0.159 0.129
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order of magnitude of each sign or symptom was approximately 
the same. A majority of participants (85.3%, n=4819), presented 
with symptoms of cough and nasal discharge. A history 
of fever was identified in n=3541 participants (62.7%), but 
declined with age from 10–19 years onwards. Symptoms indica-
tive of lower respiratory tract involvement, crackles, chest 
indrawing and fast breathing for age were uncommon (1.2%, 
n=65). The number of participants in each facility for this study 
differed significantly by the month in which recruitment occurred 
(χ2(11) =78.26, P=0.001). There were interruptions during the 
5th to 13th of December 2016 due to a health workers’ indus-
trial dispute and 1 week during the Christmas break that led to 
lower recruitment for that month. Only 56 participants were 
recruited in December from all the nine facilities out of the 585 
expected per month.
Virus detection
The prevalence of NPS collections positive for one or more 
respiratory virus target was 42.1% (n=2380). The median age 
of the virus-positive patients was 2 years (IQR, 1–9). The 
proportion of virus-positive individuals differed significantly by 
age, sex and education status, but not by sampling site (Table 2). 
The prevalence of respiratory virus detections was higher among 
young children (<5 years) than older children and adults (≥5 years) 
Table 2. Characteristics of respiratory virus positive and negative 
participants from a study of 9 outpatient health facilities in Kilifi County 
coastal Kenya over the year 2016.
Characteristic NPS virus positive(n) %
NPS virus 
negative (n) % Total(n) P value
(n=2380) 42.2 (n=3267) 57.8 (n=5647)
Age in years
Mean 8.2 14.3 11.7
Median (IQR*) 2 (1-9) 5 (1-20) 4 (1-15)
Sex
Male 1075 45 1314 55 2389 0.0001
Female 1305 40.1 1953 59.9 3258
Age Category
0–5 mths 302 57.74 221 42.26 523 0.0001
6–11 mths 276 53.38 241 46.62 517
12–23 mths 398 51.76 371 48.24 769
24–35 mths 276 50 276 50 552
3–4 yrs 271 40.57 397 59.43 668
5–9 yrs 303 39.25 469 60.75 772
10–19 yrs 242 34.52 459 65.48 701
20–49 yrs 234 29.58 557 70.42 791
50–100 yrs 78 22.03 276 77.97 354
Education
Not in school 1665 45.91 1962 54.09 3627 0.001
Kindergaten 244 35.78 438 64.22 682
Primary 412 35.61 745 64.39 1157
Secondary 54 33.33 108 66.67 162
Tertiary 5 26.32 14 73.68 19
Health Facility
Matsangoni 282 42.66 379 57.34 661 0.072
Ngerenya 263 42.08 362 57.92 625
Sokoke 255 41.4 361 58.6 616
Mtondia 317 46.21 369 53.79 686
Mavueni 293 45.85 346 54.15 639
Jaribuni 237 39.7 360 60.3 597
Chasimba 259 41.91 359 58.09 618
Junju 247 40.36 365 59.64 612
Pingilikani 227 38.28 366 61.72 593
IQR, Interquartile range; Chi2 test P value 
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(50.3% vs 32.7%, respectively; χ2 (1) =177.3, P=0.0001). Infants 
aged below 6 months with ARI constituted 9.3% (n=523) 
of the participants, and 58% (302) of these had one or more 
respiratory virus targets detected. Of all virus-positive individuals, 
70% (1665/2380) were not in any form of education, with the 
vast majority of these pre-school, i.e. 83.2% (1385/1665). During 
study piloting (month of December 2015), respiratory samples 
from 153 participants were collected; 24.2% (n=37) were 
children under 5 years of age and 37.9% (n=58) were positive 
for one or more virus.
The most common respiratory viruses detected in this study 
were rhinovirus 18.6% (n=1050), influenza virus 6.9% (n=390), 
coronavirus 6.8% (n=387), parainfluenza virus 6.6% (n=371), 
RSV 3.9% (n=219) and adenovirus 2.7% (n=155). The fre-
quency of viruses did not differ significantly by facility of 
recruitment (χ2(8) = 13.38, P=0.072) (Table 2). The distribution 
of proportions of viruses detected from each health facil-
ity were similar, with rhinovirus being the most common virus 
detected from all the sites (Figure 2). Furthermore, for each virus 
group, the proportion of all positive individuals were distributed 
roughly evenly across all health facilities, with the exception 
of HMPV (Figure 3). Note for comparison that during the pilot 
phase of December 2015 during which 56 samples were col-
lected, influenza virus type A; 37.9% (n=22), RSV; 20.6% 
(n=12) and rhinovirus; 17.2% (n=10) were the most commonly 
detected viruses.
The age distribution of detections showed variation between 
viruses (Figure 4). For example, RSV B was most frequent 
among participants 0 to 23 months, adenovirus in children 6 to 
35 months, and influenza B in those aged 5 to 19 years.
Multiple viruses were detected in 4.4% of the participants 
(n=246), with 2, 3 and 4 co-infecting viruses detected in n=221, 
n=19 and n=6 of the participants, respectively. Rhinovirus 
occurred in 153 participants with multiple viruses; coronaviruses 
in 131 participants; adenovirus in 55 participants; parainfluenza 
virus type 3 in 36 participants and RSV B in 28 participants. 
Rhinoviruses and adenoviruses co-infected with all the other 
14 target viruses while RSV group B was found not to co-infect 
with all, except HMPV.
Only 1.4% of the participants (n=33) with a virus-positive NPS 
sample were referred to the KCH for specialized management. 
Treatment given to participants with ARI symptoms who tested 
positive for any of the virus targets were: antibiotics 81.4% 
(n=1947), antihistamines (chlorphenamine maleate) 60.4% 
(n=1437) and paracetamol 86% (n=2045). The most common 
antibiotic drugs prescribed were amoxicillin (39.7%, n=945) 
and trimethoprim/sulfamethoxazole (35%, n=834). Amoxicillin/ 
clavulanic acid (0.3%, n=8) and ciprofloxacin (0.7%, n=16) were 
less commonly prescribed.
Seasonality of the detected viruses
We observed a seasonal pattern in occurrence for some of the 
viruses (Figure 5). Rhinovirus and adenovirus appeared to 
occur throughout the year. Influenza virus occurrence during 
the year differed between the types. Influenza type B, the most 
commonly detected influenza type, occurred predominantly 
between March and August. Influenza type C occurred mostly 
between September and December, while influenza type A was 
detected most commonly in January, February, November and 
December. RSV group B was predominant over RSV group A; 
cases for both groups arose predominantly in the first 4 months 
of the year. Coronavirus OC43 occurred mostly during the 
months of June to August and E229 at the end of the year; NL63 
occurred least in the third quarter of the year. Seasonal patterns 
for parainfluenza viruses and HMPV were difficult to discern.
Comparison of inpatient vs outpatient virus detections
A comparison of the distribution of viruses between the outpa-
tient and the inpatient setting among children under 5 years of 
age is shown in Figure 6. A total of 49.0% NPS samples (n=282) 
from 575 inpatients with LRTI aged under 5 years were positive 
for one of the target respiratory viruses. RSV was the most 
common virus detected among hospitalized cases of ARI, with 
significantly higher prevalence 22.1% (n=127) than for outpa-
tients 6.0% (182) (χ2(1)=159.4, P=0.0001). Adenovirus was 
also of high prevalence and significantly more common 12.4% 
(n=71) than in outpatients 4.4 % (134) (χ2(1) =56.6, P=0.0001). 
Rhinovirus was at high prevalence in both settings, but more so 
in the outpatients. Coronavirus OC43 and parainfluenza virus 
type 4 were more prevalent in outpatient than inpatients. All 
remaining viruses, though proportionally less common, showed 
higher prevalence in the outpatient setting. The distribution of 
Ct values for each virus target was similar for both inpatient 
and outpatient samples.
Discussion
In this study on the coast of Kenya, we describe the frequency 
of occurrence, and the spatial and temporal distribution of 15 
viruses associated with respiratory illness in the outpatient 
setting. We also compare the distribution of viruses associated 
with respiratory infection among children under 5 years of age in 
the outpatient and inpatient settings.
To provide baseline data for investigating the transmission 
patterns and pathways of spread for common respiratory viruses, 
we used molecular techniques to detect viruses circulating 
throughout a well-defined population of nearly 300,000 inhabit-
ants in an area of ~900 km2 in rural coastal Kenya. We observed 
a prevalence of 42% virus infection among the selected patients 
presenting with symptoms of ARI in outpatient departments 
of nine health facilities. These findings indicate that viruses are 
prominently associated with respiratory tract infections of suf-
ficient severity for individuals to seek medical attention within 
this community.
Consistent with observations elsewhere2,5,24, most of the ARI 
outpatients in this study were young children under 5 years; 
50.3% of the participants in this age group had a virus positive 
NPS sample. This demonstrates that the under 5’s are a highly 
vulnerable age group for medically important ARI. The results are 
comparable to those from the outpatient health facilities in refu-
gee camps and at a national referral hospital, in Kenya, where the 
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Figure 2. Percentage of nasopharyngeal swab samples positive for each of 15 respiratory virus targets for the nine health facilities 
(all facilities together and each individually) from ARI surveillance in the Kilifi Health and Demographic Surveillance System, Kenya, 
January to December 2016. RSVA, RSV group A; RSVB. RSV group B; HRV, human rhinovirus; PIV1-PIV4, parainfluenza virus types 1–4; 
ADV, adenovirus; OC43, human coronavirus OC43; NL63, human coronavirus NL63; E229, human coronavirus E229; FLUA-FLUC, influenza 
viruses types A-C; HMPV, human metapneumovirus.
Page 8 of 16
Wellcome Open Research 2018, 3:89 Last updated: 02 AUG 2018
Figure 3. The relative proportion of nasopharyngeal swab samples positive across nine health facilities, by virus group, through 
surveillance of ARI presentations within the Kilifi Health and Demographic Surveillance System, Kenya, January to December 2016. 
RSV, RSV A and B groups; Influenza, influenza A, B and C types; Coronaviruses, coronavirus OC43, NL63, 229e; Parainfluenza, parainfluenza 
types 1–4.
proportions of virus-positive NPS samples in those under 5 years 
old with cases of ARI was 49.8%25 and 54%26, respectively. This 
age group appears to experience the highest burden of acute 
illnesses linked to the studied respiratory viruses and should 
therefore be a focus for future intervention strategies. However, 
additional data should be collected on the social and economic 
burden of these viruses, such as days of school missed, medical 
costs and time off work for caregivers.
Of all virus-positive patients presenting to the outpatient facili-
ties, only a small proportion (30%) were in education (mostly 
kindergarten or primary.) This is of interest as the school age 
groups might be expected to be important agents in the commu-
nity spread of infectious disease, certainly given their high rates of 
contact through which transmission is presumed to be effected27,28. 
There is need for empirical evidence to define the relationship 
between contact rates and respiratory virus transmission.
The most frequently detected virus in this study was rhinovirus. 
This is in accordance with previous community-based studies, 
for example the Tecumseh project in Michigan29. Serological and 
molecular epidemiological studies show rhinoviruses to exist 
as many types (currently over 160)10,21, with little cross-type 
protection (amongst those classified immunologically), which 
may explain the high prevalence and absence of seasonality 
in respiratory illness caused by rhinovirus infection in the 
community. Persistence of rhinovirus might be ascribed to the 
frequent introduction of new virus strains into the community 
unconstrained by prior circulation of other types.
In this study, we did not see any major difference in distribution 
of viruses across the health facilities. This could have been 
attributed to the relatively small size of the demographic surveil-
lance system area (891 km2). This allows for the possibility of 
population mixing and frequent interactions, especially during 
social events, leading to the rapid spread of viruses across the 
KHDSS area. However, definitive understanding of the temporal 
and spatial patterns of spread requires the addition of sequence 
data to infer relatedness of circulating viruses.
Influenza, RSV and coronavirus exhibit a clear seasonality 
pattern in occurrence, whereas rhinovirus and adenovirus are 
detected throughout the year. Of note is that during the first 
quarter of the year, other than rhinovirus, RSV is predominant 
amongst the detected viruses. Currently little is known about the 
mechanisms underlying virus dominance, interaction, co-existence 
and competition. Studies are warranted to investigate occur-
rence and interactions of multiple respiratory viruses in the 
nasopharynx of the individual over time (i.e. across the seasons), 
and to explore the possible effect of eliminating a virus such as 
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Figure 4. Age-distribution of detections of 15 virus targets in nasopharyngeal swabs (NPS) identified from ARI surveillance at nine 
health facilities in the Kilifi Health and Demographic Surveillance System, Kenya, January to December 2016. The primary Y axis shows 
frequency while secondary Y axis shows proportion in each age group. RSVA, RSV group A; RSVB. RSV group B; HRV, human rhinovirus; 
PIV1–PIV4, parainfluenza virus types 1–4; ADV, adenovirus; OC43, human coronavirus OC43; NL63, human coronavirus NL63; E229, human 
coronavirus E229; FLUA-FLUC, influenza viruses types A–C; HMPV, human metapneumovirus.
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Figure 5. The distribution by month of the proportion of virus-positive nasopharyngeal swab samples over the period January 
to December 2016 for each of 15 virus targets, obtained through ARI surveillance at nine health facilities in the Kilifi Health and 
Demographic Surveillance System, Kenya. Secondary Y axis records number of samples collected from recruits per month. RSVA, 
RSV group A; RSVB. RSV group B; HRV, human rhinovirus; PIV1-PIV4, parainfluenza virus types 1-4; ADV, adenovirus; OC43, human 
coronavirus OC43; NL63, human coronavirus NL63; E229, human coronavirus E229; FLUA-FLUC, influenza viruses types A-C; HMPV, human 
metapneumovirus.
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Figure 6. Virus surveillance comparison between inpatient and outpatient facilities for children under 5 years in the Kilifi Health and 
Demographic Surveillance System (KHDSS), Kenya, 2016. Panel A compares the proportion of nasopharyngeal swab samples positive for 
each of the 15 virus targets in samples collected from severe pneumonia admissions to Kilifi County Hospital (grey bars) and from outpatients 
presenting to nine health facilities (black bars). Violin plots show the distribution (median, IQR) for detectable rtPCR cycle threshold (Ct) 
values (i.e. Ct<=40) from respiratory samples for KHDSS outpatients (B) and for KCH inpatients (C). Threshold used for determining positive 
and negative samples shown by dashed line (Ct=35.0). RSVA, RSV group A; RSVB. RSV group B; HRV, human rhinovirus; PIV1-PIV4, 
parainfluenza virus types 1-4; ADV, adenovirus; OC43, human coronavirus OC43; NL63, human coronavirus NL63; E229, human coronavirus 
E229; FLUA-FLUC, influenza viruses types A-C; HMPV, human metapneumovirus.
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RSV through vaccination. Such information will be useful to 
guide policy on priority respiratory viruses to focus for 
intervention.
We also find the wide use of antibiotics to treat majority of 
patients presenting with symptoms of ARI most likely caused 
by viruses. This raises concern over antimicrobial stewardship, 
with increased risk of antimicrobial resistance to first-line 
antibiotic agents and unnecessary use of expensive second-line 
antibiotics in treating mild acute respiratory disease.
In contrast to the outpatient setting, where rhinovirus is the 
most common virus associated with ARI among children under 
5 years; in the inpatient setting, RSV and adenovirus are the 
leading cause of severe respiratory illness. From the long-term 
in-patient surveillance at KCH the observation for RSV is not 
unusual, but 2016 had an unusually high occurrence of adeno-
virus cases (data not shown for other years). The pattern in 
distribution of virus load (equated to Ct values) suggests that the 
cut off of 35.0 for the MPX real time PCR diagnostic method 
is generally suitable for all viruses, both in outpatient and inpa-
tients (i.e. irrespective of disease severity and possible viral load), 
excepting for HMPV, PIV-1 and CoV 22E in outpatients and 
PIV-2 in inpatients and outpatients, where sensitivity may be an 
issue and a contributor to low prevalence in this study.
The major limitation of this study is that data are for 1 year only 
and caution should be applied in inferring seasonal patterns. 
This is exacerbated by the low numbers of participants recruited 
in December due to countrywide industrial action by nurses. 
In addition, there is competition for viruses due to the design of 
sampling we used, of selected 15 samples per facility per week. 
An epidemic for one target virus might influence the proportions 
of other viruses observed but this might not necessarily imply 
seasonality. The detection of multiple viruses in one individual 
makes it difficult to determine the viral pathogen responsi-
ble for the respiratory illness at the time of recruitment. Only 
a sub-sample of all ARI presentations were recruited and 
the underlying denominator not recorded, which prevents an 
estimation of community incidence of presentations that would be 
useful for comparative purposes.
Conclusions
In a sample of 5647 participants, about 40% of the ARI outpa-
tient visits to the Kenyan Coast were associated with respira-
tory virus infection. Virus ARI is predominant among children 
<5 years, and relatively uncommon amongst school-going chil-
dren. Rhinoviruses, influenza viruses, parainfluenza viruses, coro-
naviruses and RSV are most commonly associated with ARI over 
one year of community surveillance, whereas RSV and adenovi-
ruses are the predominant respiratory virus among hospitalized 
patients with ARI. Virus occurrence (temporal and age-related) 
is similar across all facilities within the KHDSS area. Studies 
of the socio-economic implications of this burden are war-
ranted, especially for rhinovirus infections that predominated. 
Further analysis of virus sequence data will delineate patterns of 
spread of viruses causing ARI illness in this setting.
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